Servicio Andaluz de Salud or Andalusian Health Service (SAS) is an autonomous body attached to the Ministry of Health of the Government of Andalusia
Servicio Andaluz de Salud or Andalusian Health Service (SAS) is an autonomous body attached to the Ministry of Health of the Government of Andalusia. Its mission is to provide quality public health care to the citizens, seeking efficiency and optimum use of resources. SAS is the main healthcare provider for 8.302.923 inhabitants. It has a network of integrated care services to ensure accessibility: 1,491 primary care centers, 29 hospitals and 84,706 employees.
The SAS’s Virgen del Rocío University Hospital (VRUH) located in Seville, is the reference healthcare provider and one of the largest hospitals in Spain.
The Health and Biomedical Informatics R&D group, and the Internal Medicine Department for Integrated Care of VRUH, will develop SAS activities within this project.
The Health and Biomedical Informatics R&D group, leads by Carlos Parra, has relevant experience in health informatics standards, clinical information modelling, interoperability, telemedicine, decision support, and natural language processing in Electronic Health Records, among others. The research group is currently involved in several EU-funded initiatives and projects (see below). This group is located in the Biomedical Research Institute of Seville (IBIS), where other 35 basic and translational research group also develop their projects within one of the largest Biomedical Research Institutes in Spain.
The Internal Medicine Department for Integrated Care (IMDIC) has turned into an innovative model of the Andalusian Public Health System with national and international scope in the planning, organization and health resources management aimed at comprehensive attention and continuous healthcare delivery. It is with to highlight its ability to generate and transfer knowledge and innovation in healthcare delivery. It is a pioneer entity in the definition, attention and monitoring of polypathological patients with comorbidities and functional limitations backed up by many scientific publications.
IBIS is mainly supported by national public and European Union funds. IBIS is focused on the development of basic, clinical and translational biomedical research, with the aim to undertake high quality and competitive research at international level on the most prevalent diseases and the development of new methods of diagnosis and treatment. IBIS is based on fundamental research at the molecular and cellular level with a view to promote the rapid transfer of knowledge to the clinical setting, at the same time improving the quality of clinical and epidemiological research.
Research at VRUH is managed by the Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla – FISEVI. FISEVI handles the financial and administrative aspects of the VRUH involvement in RTD actions — including issues related to employment and payment of personnel, purchase of equipment, consumables, etc. — with the aim to improve and rationalise the administrative and financial management.